Biotech grants in Belgium
Explore Biotech grants for companies in Belgium. This list brings together funding for drug discovery, diagnostics, cell and gene therapy, biomanufacturing and life-science research from Belgian innovation agencies, research funders and foundations, EU and international programs open to applicants in Belgium, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at Biotech in Belgium come first.
Showing 217-240 of 676 grants
PMV Start Loan
🇧🇪PMV · Belgium
Provides PMV Start Loan support for early companies, independent professionals, and freelancers in Flanders through concessional financing.
Prospecting Trip Outside the EEA (Prospectiereis Buiten EER)
🇧🇪FIT · Belgium
Supports Flemish prospecting missions for market exploration beyond the European Economic Area.
R&D Feasibility Study (O&O haalbaarheidsstudie)
🇧🇪VLAIO · Belgium
Offers Flemish businesses with matched support for short feasibility studies shaping future innovation.
Research Project (Onderzoeksproject)
🇧🇪VLAIO · Belgium
Funds Flemish companies with industrial-research grants for project-driven innovation and applied commercial development.
BEL-COO (Trans-regional Innovation Project)
🇧🇪VLAIO · Belgium
Funds cross-regional Flemish cooperation by coordinating shared support routes for industrial projects.
Innovation Mandates — Call 2026A (Innovatiemandaten)
🇧🇪VLAIO · Belgium
Supports postdoctoral research mandates bridging basic research into industrial applications with Flemish valorisation.
Innovative Startup Support (Innovatieve starterssteun)
🇧🇪VLAIO · Belgium
Provides Belgium innovators with hands-on guidance for first startup innovation grants with specialist coaching and commercialization planning.
Starter Package for Internationalization (Starterspakket Internationalisering)
🇧🇪FIT · Belgium
Funds first-time Flemish exporters launching international sales with flat-rate export grants.
Belgium Innovation Income Deduction
🇧🇪FPS Finance · Belgium
Funds Belgian companies with innovation deductions that strengthen spending on new products and services.
Innovation Clusters (Innovatieclusters)
🇧🇪VLAIO · Belgium
Supports the VLAIO Innovatieve Bedrijfsnetwerken program that connects Flemish enterprise consortia and co-finances collaborative innovation clusters.
Welvaartsfonds (Wealth Fund)
🇧🇪PMV · Belgium
Offers Welvaartsfonds as a recovery support facility for Flemish companies needing mezzanine financing support during stress periods.
GREGoRi Innovation Projects
NIH · United States
Funds a genuinely new experimental or computational approach to finding the cause of a rare genetic disorder, where the current state of the art falls short.
FY26 Reconstructive Transplant Research Program Concept Award
CDMRP · United States
Funds small, high-risk exploratory research into reconstructive transplantation and vascularized composite allotransplantation for wounded Service Members and Veterans.
Xcelerate Champion of Innovation
WHX Tech · United Arab Emirates
Pays an equity-free cash prize to the top healthcare startup pitching live at WHX Tech's Xcelerate competition in Dubai.
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01)
NIH · United States
Funds theory and method development on how genetic and non-genetic factors together produce variation in complex traits, tested against large existing datasets.
Strategic Research Agreement — Round 1
Breakthrough T1D · United States
Funds investigator-led type 1 diabetes research partnerships across preclinical discovery, treatment, and translational priorities.
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01)
NIH · United States
Funds new analysis of clinical, genomic, environmental and registry data that already exists, to sharpen who is at risk of cancer and what happens to them.
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research
NIH · United States
Funds the development and hard technical validation that turns a working cancer research technology into one other laboratories will actually adopt.
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research
NIH · United States
Funds proof-of-concept work on a genuinely new tool, assay, platform or instrument for characterising cancer cells or handling biospecimens.
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21)
NIH · United States
Funds the same reanalysis of already-collected cancer data on a smaller, exploratory footing, for teams that do not need a full research project award.
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant
NIH · United States
Funds exploratory studies of the ethical, legal and social consequences of human genetics, especially where a technology or a use of genomic data is new.
Ethical, Legal and Social Implications (ELSI) Research
NIH · United States
Funds a full research project on the ethics, law and social effects of human genetics — and refuses to review an application with no diverse-perspectives plan.
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD)
NIH · United States
Funds one bundled run from first-in-human through phase 2a for a dementia drug that works on something other than amyloid or tau.
Lupus Insight Prize
LRA · United States
Provides prize recognizing a specific significant recent lupus research discovery through the Lupus Insight Prize.